These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

709 related items for PubMed ID: 2994987

  • 1. Natriuretic effect and changes in renal haemodynamics induced by enalapril in essential hypertension.
    Sánchez RA, Marcó E, Gilbert HB, Raffaele P, Brito M, Giménez M, Moledo LI.
    Drugs; 1985; 30 Suppl 1():49-58. PubMed ID: 2994987
    [Abstract] [Full Text] [Related]

  • 2. Effect of inhibition of converting enzyme on renal hemodynamics and sodium management in polycystic kidney disease.
    Torres VE, Wilson DM, Burnett JC, Johnson CM, Offord KP.
    Mayo Clin Proc; 1991 Oct; 66(10):1010-7. PubMed ID: 1921483
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Influence of angiotensin converting enzyme inhibition and angiotensin II type 1 receptor antagonism on renal sodium and water handling and albuminuria during infusion of atrial natriuretic factor into healthy volunteers.
    Vervoort G, Hertenberg F, Wetzels JF, Smits P.
    J Hypertens; 1998 Feb; 16(2):245-50. PubMed ID: 9535153
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effects of perindopril on renal haemodynamics and natriuresis in essential hypertension.
    Chaignon M, Barrou Z, Ayad M, Lucsko M, Aubert P, Perret L, Guedon J.
    J Hypertens Suppl; 1988 Dec; 6(3):S61-4. PubMed ID: 3225690
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Angiotensin II suppression in humans by the orally active renin inhibitor Aliskiren (SPP100): comparison with enalapril.
    Nussberger J, Wuerzner G, Jensen C, Brunner HR.
    Hypertension; 2002 Jan; 39(1):E1-8. PubMed ID: 11799102
    [Abstract] [Full Text] [Related]

  • 11. Comparison of the renal effects of angiotensin converting enzyme inhibitor and calcium antagonist in hypertensive type 2 (non-insulin-dependent) diabetic patients with microalbuminuria: a randomised controlled trial.
    Baba T, Murabayashi S, Takebe K.
    Diabetologia; 1989 Jan; 32(1):40-4. PubMed ID: 2540054
    [Abstract] [Full Text] [Related]

  • 12. Comparison of enalapril and valsartan in cyclosporine A-induced hypertension and nephrotoxicity in spontaneously hypertensive rats on high-sodium diet.
    Lassila M, Finckenberg P, Pere AK, Krogerus L, Ahonen J, Vapaatalo H, Nurminen ML.
    Br J Pharmacol; 2000 Jul; 130(6):1339-47. PubMed ID: 10903974
    [Abstract] [Full Text] [Related]

  • 13. The persistent effect of long-term enalapril on pressure natriuresis in spontaneously hypertensive rats.
    Dukacz SA, Adams MA, Kline RL.
    Am J Physiol; 1997 Jul; 273(1 Pt 2):F104-12. PubMed ID: 9249597
    [Abstract] [Full Text] [Related]

  • 14. Renal and endocrine response to saline infusion in essential hypertension.
    Rydstedt LL, Williams GH, Hollenberg NK.
    Hypertension; 1986 Mar; 8(3):217-22. PubMed ID: 3005169
    [Abstract] [Full Text] [Related]

  • 15. Effects of enalaprilic acid on sodium excretion and renal hemodynamics in essential hypertension.
    Navis G, de Jong PE, Donker AJ, van der Hem GK, de Zeeuw D.
    J Clin Hypertens; 1985 Sep; 1(3):228-38. PubMed ID: 3012004
    [Abstract] [Full Text] [Related]

  • 16. Reduced activity of the kallikrein-kinin system predominates over renin-angiotensin system overactivity in all conditions of sodium balance in essential hypertensives and family-related hypertension.
    Sànchez R, Nolly H, Giannone C, Baglivo HP, Ramírez AJ.
    J Hypertens; 2003 Feb; 21(2):411-7. PubMed ID: 12569273
    [Abstract] [Full Text] [Related]

  • 17. Glomerular hyperfiltration in essential hypertension: hormonal aspects.
    Regolisti G, Buzio C, Cavatorta A, De Martin L, Cavalli R, Perazzoli F, Coghi P, Cabassi A, Pucci F, Borghetti A.
    Acta Biomed Ateneo Parmense; 1992 Feb; 63(1-2):163-73. PubMed ID: 1340661
    [Abstract] [Full Text] [Related]

  • 18. Natriuretic and hypotensive effect of adenosine-1 blockade in essential hypertension.
    van Buren M, Bijlsma JA, Boer P, van Rijn HJ, Koomans HA.
    Hypertension; 1993 Nov; 22(5):728-34. PubMed ID: 8225532
    [Abstract] [Full Text] [Related]

  • 19. Effects of enalapril maleate on blood pressure, renin-angiotensin-aldosterone system, and peripheral sympathetic activity in essential hypertension.
    Cerasola G, Cottone S, D'Ignoto G, Grasso L, Carone MB, Carapelle E, Contorno A.
    Clin Ther; 1987 Nov; 9(4):390-9. PubMed ID: 3038326
    [Abstract] [Full Text] [Related]

  • 20. Factors determining the blood pressure response to enalapril and nifedipine in hypertension associated with NIDDM.
    Chan JC, Nicholls MG, Cheung CK, Law LK, Swaminathan R, Cockram CS.
    Diabetes Care; 1995 Jul; 18(7):1001-6. PubMed ID: 7555530
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.